I thought Joe started the call mentioning they had 3 x S1's out for GNBT and 2 approved by the SEC and 3 x S1's out for NGIO that are pending approval and in relation to listing the stock on the Nasdaq. Did I hear that right for those who were on the call
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links